# A RANDOMIZED, DOUBLE-BLIND TRIAL OF BASILIXIMAB IMMUNOPROPHYLAXIS PLUS TRIPLE THERAPY IN KIDNEY TRANSPLANT RECIPIENTS1,2

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-randomized-double-blind-trial-of-basiliximab-immunoprophylaxis-plus-triple/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Claudio Ponticelli,Alexander Yussim,V. Cambi,Christophe Legendre,Gaetano Rizzo,Maurizio Salvadori,Delawir Kahn,Habib Kashi,K. Salmela,Lutz Fricke,Uwe Heemann,Javier García-Martínez,Robert I. Lechler,H. Prestele,Danièle Girault |
| Citations | 144 |
| DOI | 10.1097/00007890-200110150-00014 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2089268585 |
| PMID | 11602853 |
| Type | article |
| Year | 2001 |

## Paper authors

- [Claudio Ponticelli](https://scholariq.org/researchers/claudio-ponticelli/)

## Paper journal

- [Transplantation](https://scholariq.org/journals/transplantation/)

## Paper primary topic

- [Cytomegalovirus and herpesvirus research](https://scholariq.org/topics/cytomegalovirus-and-herpesvirus-research/)

## Paper topics

- [Cytomegalovirus and herpesvirus research](https://scholariq.org/topics/cytomegalovirus-and-herpesvirus-research/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Viral-associated cancers and disorders](https://scholariq.org/topics/viral-associated-cancers-and-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.